DrugPatentWatch Database Preview

Details for Patent: 8,734,847

Which drugs does patent 8,734,847 protect, and when does it expire?

Patent 8,734,847 protects TIVORBEX and is included in one NDA.

This patent has thirty-four patent family members in twenty countries.

Summary for Patent: 8,734,847

Title:	Formulation of indomethacin
Abstract:	The present invention relates to methods for producing particles of indomethacin using dry milling processes as well as compositions comprising indomethacin, medicaments produced using indomethacin in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of indomethacin administered by way of said medicaments.
Inventor(s):	Dodd; Aaron (Nedlands, AU), Meiser; Felix (Claremont, AU), Norret; Marck (Darlington, AU), Russell; Adrian (Rivervale, AU), Bosch; H William (Bryn Mawr, PA)
Assignee:	Iceutica Py Ltd. (Philadelphia, PA)
Application Number:	13/776,536
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 8,734,847

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Iroko Pharms Llc	TIVORBEX	indomethacin	CAPSULE;ORAL	204768-001	Feb 24, 2014		RX	Yes	No	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Iroko Pharms Llc	TIVORBEX	indomethacin	CAPSULE;ORAL	204768-002	Feb 24, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Foreign Priority and PCT Information for Patent: 8,734,847

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Australia	2009901745	Apr 24, 2009

Non-Orange Book US Patents Family Members for Patent 8,734,847

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
9,522,135	Formulation of indomethacin	➤ Sign Up
8,992,982	Formulation of indomethacin	➤ Sign Up
9,849,111	Formulation of indomethacin	➤ Sign Up
9,095,496	Formulation of indomethacin	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 8,734,847

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Ukraine	106231	➤ Sign Up
Tunisia	2011000544	➤ Sign Up
Singapore	10201401695V	➤ Sign Up
Singapore	175315	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 8,734,847

Foreign Priority and PCT Information for Patent: 8,734,847

For more information try a trial or see the plans and pricing